Hormos Medical

Hormos Medical Corporation is a biopharmaceutical company based in Turku, Finland, focused on research and development of products to treat a range of endocrine disorders associated with aging. The most advanced drugs in development are ospemifene for the treatment of conditions and symptoms associated with declining estrogen levels in postmenopausal women, and fispemifene for the treatment of androgen deficiency and associated conditions in elderly males, now entering clinical phase III and II, respectively. From its headquarters and manufacturing facility in Locarno, Switzerland, Linnea specialises in the manufacture of botanicals extracts and phyto-chemicals, and is a leading supplier to the pharmaceutical, dietary supplement and cosmetic industries.